IL326042A - חומרי אוליגונוקלאוטידים דו-גדיליים ושימושים בהם - Google Patents

חומרי אוליגונוקלאוטידים דו-גדיליים ושימושים בהם

Info

Publication number
IL326042A
IL326042A IL326042A IL32604226A IL326042A IL 326042 A IL326042 A IL 326042A IL 326042 A IL326042 A IL 326042A IL 32604226 A IL32604226 A IL 32604226A IL 326042 A IL326042 A IL 326042A
Authority
IL
Israel
Prior art keywords
double
stranded oligonucleotide
oligonucleotide agents
agents
stranded
Prior art date
Application number
IL326042A
Other languages
English (en)
Original Assignee
Bisirna Therapeutics Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bisirna Therapeutics Pte Ltd filed Critical Bisirna Therapeutics Pte Ltd
Publication of IL326042A publication Critical patent/IL326042A/he

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/312Phosphonates
    • C12N2310/3125Methylphosphonates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/317Chemical structure of the backbone with an inverted bond, e.g. a cap structure
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3212'-O-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3222'-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
IL326042A 2023-07-21 2024-07-19 חומרי אוליגונוקלאוטידים דו-גדיליים ושימושים בהם IL326042A (he)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202310904516 2023-07-21
CN202310900474 2023-07-21
CN202311532296 2023-11-16
CN202410396475 2024-04-02
PCT/CN2024/106419 WO2025021034A1 (en) 2023-07-21 2024-07-19 Double-stranded oligonucleotide agents and uses thereof

Publications (1)

Publication Number Publication Date
IL326042A true IL326042A (he) 2026-03-01

Family

ID=94374144

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326042A IL326042A (he) 2023-07-21 2024-07-19 חומרי אוליגונוקלאוטידים דו-גדיליים ושימושים בהם

Country Status (7)

Country Link
KR (1) KR20260048569A (he)
CN (1) CN121816417A (he)
AR (1) AR133304A1 (he)
AU (1) AU2024298074A1 (he)
IL (1) IL326042A (he)
TW (1) TW202519663A (he)
WO (1) WO2025021034A1 (he)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120118909B (zh) * 2025-05-14 2026-02-06 北京悦康科创医药科技股份有限公司 靶向调控LPA基因表达的siRNA双链体及其在预防和治疗心脑血管相关疾病中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003040294A2 (en) * 2001-11-05 2003-05-15 Janssen Pharmaceutica N.V. METHOD FOR THE IN VITRO SYNTHESIS OF SHORT DOUBLE STRANDED RNAs
WO2011163121A1 (en) * 2010-06-21 2011-12-29 Alnylam Pharmaceuticals, Inc. Multifunctional copolymers for nucleic acid delivery
EP2780454A2 (en) * 2011-11-18 2014-09-24 Alnylam Pharmaceuticals, Inc. Modified rnai agents
EP3549610A1 (en) * 2018-04-05 2019-10-09 Silence Therapeutics GmbH Nucleic acid conjugates
CN117858946A (zh) * 2021-05-29 2024-04-09 强新科技国际研究院 作为新型基因沉默技术的非对称短双链体dna及其应用
CN118369428A (zh) * 2021-05-29 2024-07-19 强新科技国际研究院 作为新型基因沉默技术的短双链体dna及其应用

Also Published As

Publication number Publication date
AR133304A1 (es) 2025-09-17
WO2025021034A1 (en) 2025-01-30
CN121816417A (zh) 2026-04-07
TW202519663A (zh) 2025-05-16
KR20260048569A (ko) 2026-04-10
AU2024298074A1 (en) 2026-02-19

Similar Documents

Publication Publication Date Title
IL318761A (he) הרכבי אוליגונוקליאוטידים ושיטות שלהם
IL316178A (he) הרכבי אוליגונוקליאוטידים ושיטות הקשורות אליהם
IL311625A (he) הרכבי אוליגונוקלאוטידים ושיטות שלהם
EP4114939A4 (en) OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
SG11202107318YA (en) Oligonucleotide compositions and methods thereof
IL325571A (he) הרכבי אוליגונוקליאוטידים ושיטות שלהם
IL304334A (he) אוליגונוקליאוטידים דו-גדיליים שעברו שינוי
IL312184A (he) הרכבי דנ" א ושיטות קשורות
ZA202305094B (en) Oligonucleotide and use thereof against hepatitis b virus and hepatitis d virus
IL326042A (he) חומרי אוליגונוקלאוטידים דו-גדיליים ושימושים בהם
IL316714A (he) קומפוזיציות של אוליגונוקלאוטידים ושיטות לכך
IL313171A (he) וריאנטים של il10 ושימושים שלהם
EP3913055A4 (en) DOUBLE STRANDED OLIGONUCLEOTIDE TARGETED AGAINST DKK1 GENE, CONSTRUCT AND COMPOSITION CONTAINING SAME FOR PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH THEREFOR
PL4326068T3 (pl) Środek odkażający i jego zastosowanie
IL318437A (he) הרכבים המכילים אוליגונוקלאוטידים, ושיטות לשימוש בהם
CA3299403A1 (en) Double-stranded oligonucleotide agents and uses thereof
IL321537A (he) ליגאזות rna דו-גדיליות מהונדסות ושימושיהן
CA3244821A1 (en) Antisense oligonucleotides and their uses
DE602004022921D1 (de) Antisense oligonukleotide, die die ausprägungsstufe von hif-1 hemmen
IL313773A (he) שימוש באוליגונוקלאוטיד nlrp3 למניעה ו/או טיפול של מחלות דלקתיות
IL316990A (he) חומרים קושרים her2 ושימושים בהם
GB202114871D0 (en) Guide RNA and uses thereof
EP3757212A4 (en) DOUBLE PROPELLER OLIGONUCLEOTID CONSTRUCTION INCLUDING A DOUBLE STRAND MIARN AND ITS USE
CA3292551A1 (en) Double-stranded oligonucleotide, conjugate thereof, and use thereof
SG11202110745VA (en) Angptl2 antisense oligonucleotides and uses thereof